tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher Marai, 138 are a BUY (86.25%), 7 are a HOLD (4.38%), 15 are a SELL (9.38%).
Analyst Christopher Marai, carries an average stock price target met ratio of 56.75% that have a potential upside of 64.65% achieved within 400 days. Previously, Christopher Marai worked at NOMURA, OPPENHEIMER.
Christopher Marai’s has documented 317 price targets and ratings displayed on 28 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRBP, Corbus Pharmaceuticals at 04-Jun-2020.
Analyst best performing recommendations are on DCPH (DECIPHERA PHARMACEUTICALS LLC).
The best stock recommendation documented was for DCPH (DECIPHERA PHARMACEUTICALS LLC) at 10/23/2017. The price target of $57 was fulfilled within 31 days with a profit of $36.21 (174.17%) receiving and performance score of 56.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$489
$32.96 (7.23%)
$296
2 days ago
(31-Oct-2025)
48/49 (97.96%)
$32.96 (7.23%)
437
Buy
$527
$70.96 (15.56%)
$329
2 days ago
(31-Oct-2025)
17/18 (94.44%)
$70.96 (15.56%)
256
Buy
$549
$92.96 (20.38%)
$384
3 days ago
(30-Oct-2025)
8/9 (88.89%)
$99.44 (22.12%)
108
Buy
$473
$16.96 (3.72%)
$348
20 days ago
(13-Oct-2025)
9/9 (100%)
$8.05 (1.73%)
27
Buy
$495
$38.96 (8.54%)
$345
27 days ago
(06-Oct-2025)
18/19 (94.74%)
$43 (9.51%)
240
What Year was the first public recommendation made by Christopher Marai?
